Related Experiment Videos
[Urolithiasis in cystic fibrosis].
S Nathanson1, F Frere, E Tassin
1Service de pédiatrie-néonatologie, hôpital André-Mignot, centre hospitalier de Versailles, 177, rue de Versailles, 78157 Le Chesnay cedex, France. snathan@ch-versailles.fr
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|September 16, 2003
Summary
Cystic fibrosis patients have a higher risk of urolithiasis. A 12-year-old with cystic fibrosis successfully treated for calcium oxalate kidney stones highlights the importance of management.
Area of Science:
- Nephrology
- Pediatrics
- Genetics
Background:
- Urolithiasis is more common in cystic fibrosis (CF) patients compared to the general population.
- Understanding the mechanisms of stone formation in CF is crucial for effective prevention and treatment.
Observation:
- A 12-year-old patient with cystic fibrosis presented with flank pain.
- Diagnostic evaluation revealed the presence of calcium oxalate urolithiasis.
Findings:
- The patient's condition improved with a combination of pharmacological and dietary interventions.
- Key mechanisms contributing to lithogenesis in cystic fibrosis were identified.
Implications:
- This case underscores the need for vigilant monitoring and tailored management strategies for urolithiasis in pediatric CF patients.
- Early detection and appropriate treatment can lead to favorable outcomes, preventing complications associated with kidney stones.